Long-Term Efficacy of Lutonix in a Real-World Femoropopliteal Patients With Peripheral Arterial Disease: Insights From the SAFE-DCB US Registry - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Long-Term Effectiveness of Lutonix in Real-World Patients with Femoropopliteal Peripheral Arterial Disease: Findings from the SAFE-DCB US Registry

  • By

  • Nicolas W. Shammas

  • Dion Franga

  • Erin Moore

  • George Mueller

  • Thomas P. Davis

  • Edward Woo

  • Investigators of SAFE-DCB US Registry

  • June 29, 2026

Share

Original Source(s)

Related Content